Skip to main content
. 2011 Jul;55(7):3609–3612. doi: 10.1128/AAC.01313-10

Table 1.

Checkerboard analysis of in vitro interaction between TCL and FLC against 24 clinical isolates of C. albicansa

Drug Median MIC-2 endpoint (range) of drug (μg/ml)
Median MIC-1 endpoint (range) of drug (μg/ml)
Alone In combination Alone In combination
FLC 16 (4–32) 1 (1–2) 256 (64–>512) 2 (1–4)
TCL 32 (32–64) 8 (4–8) 64 (32–64) 8 (8–16)
a

TCL, triclosan; FLC, fluconazole.